首页> 外文期刊>Frontiers in Medicine >CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver
【24h】

CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver

机译:CML / RAGE信号桥接动脉粥样硬化和非酒精性脂肪肝之间的常见发病机制

获取原文
获取外文期刊封面目录资料

摘要

Non-alcoholic fatty liver disease (NAFLD) has become a common chronic disease in the world. NAFLD is not only a simple intrahepatic lesion, but also affects the occurrence of a variety of extrahepatic complications. In particular, cardiovascular complications are particularly serious, which is the main cause of death in patients with nonalcoholic fatty liver disease. To study the association betweenNAFLD and AS. It may be a new way to improve the quality of life of patients with nonalcoholic fatty liver disease. As we all known, inflammatory response plays an important role in the occurrence and development of NAFLD and AS. In this study, we found that the accumulation of N ε - carboxymethyllysine(CML) in the liver leads to hepatic steatosis. CML can induce the expression of interleukin (IL)-1β,interleukin (IL)-6, tumor necrosis factor (TNF)-α,C-reactionprotein(CRP) by binding with advanced glycosylation end-product receptor (RAGE) and accelerate the development of atherosclerosis. After silencing RAGE expression, the expression of pro-inflammatory cytokines was inhibited and liver vascular pathological changes were relieved. In conclusion, CML / RAGE signal promotes the progression of non-alcoholic fatty liver disease and atherosclerosis. We hope to provide new ideas for the study of liver vascular dialogue in multi organ communication.
机译:非酒精脂肪肝病(NAFLD)已成为世界常见的慢性疾病。 NAFLD不仅是一种简单的肝内病变,而且影响各种侵袭性并发症的发生。特别是,心血管并发症特别严重,这是非酒精性脂肪肝病患者死亡的主要原因。研究介绍联系,介于Nafld和As。这可能是提高非酒精性脂肪肝病患者的生活质量的新方法。  我们  all 已知的,炎症反应在Nafld的发生和发展中发挥着重要作用。在这项研究中,我们发现肝脏中Nε - 羧甲基氰基(CML)的积累导致肝脏脂肪变性。 CML可以通过与先进的糖基化最终产物受体(RAGE)结合并加速来诱导白细胞介素(IL)-1β,白细胞介素(IL)-1β,白细胞介素(IL)-6,肿瘤坏死因子(TNF)-α,C-反应蛋白(CRP)并加速动脉粥样硬化的发展。在沉默腐败表达后,抑制促炎细胞因子的表达,并抑制了肝脏血管病理变化。总之,CML / RAGE信号促进非酒精性脂肪肝病和动脉粥样硬化的进展。我们希望为多器官沟通中肝脏血管对话的研究提供新的思路。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号